Bradbury BD - Search Results

1

Cinacalcet and gastrointestinal bleeding risk in patients receiving hemodialysis.

Liu J, Guo H, Lin TC, Wetmore JB, Bradbury BD, Gilbertson DT, Nieman K, Peng Y, Sprafka JM, Dluzniewski PJ. Liu J, et al. Among authors: bradbury bd. Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):141-148. doi: 10.1002/pds.5337. Epub 2021 Aug 19. Pharmacoepidemiol Drug Saf. 2022. PMID: 34363294

2

Hemoglobin level variability: associations with mortality.

Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Gilbertson DT, et al. Among authors: bradbury bd. Clin J Am Soc Nephrol. 2008 Jan;3(1):133-8. doi: 10.2215/CJN.01610407. Epub 2007 Nov 28. Clin J Am Soc Nephrol. 2008. PMID: 18045862 Free PMC article.

3

Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia.

Collins AJ, Guo H, Gilbertson DT, Bradbury BD. Collins AJ, et al. Among authors: bradbury bd. Nephron Clin Pract. 2009;111(2):c141-8. doi: 10.1159/000191207. Epub 2009 Jan 16. Nephron Clin Pract. 2009. PMID: 19147996

4

Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.

Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA. Bradbury BD, et al. Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):932-40. doi: 10.1002/pds.1799. Pharmacoepidemiol Drug Saf. 2009. PMID: 19572312

5

Hemoglobin level variability: anemia management among variability groups.

Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ. Gilbertson DT, et al. Am J Nephrol. 2009;30(6):491-8. doi: 10.1159/000243565. Epub 2009 Sep 29. Am J Nephrol. 2009. PMID: 19786739 Free article. Review.

6

Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.

Wang O, Kilpatrick RD, Critchlow CW, Ling X, Bradbury BD, Gilbertson DT, Collins AJ, Rothman KJ, Acquavella JF. Wang O, et al. Among authors: bradbury bd. Clin J Am Soc Nephrol. 2010 Feb;5(2):182-8. doi: 10.2215/CJN.03040509. Epub 2009 Dec 17. Clin J Am Soc Nephrol. 2010. PMID: 20019122 Free PMC article.

7

Hemoglobin variability and mortality: confounding by disease severity.

Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Weinhandl ED, et al. Among authors: bradbury bd. Am J Kidney Dis. 2011 Feb;57(2):255-65. doi: 10.1053/j.ajkd.2010.06.013. Am J Kidney Dis. 2011. PMID: 20801571

8

Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.

Bradbury BD, Gilbertson DT, Brookhart MA, Kilpatrick RD. Bradbury BD, et al. Adv Chronic Kidney Dis. 2012 Jan;19(1):19-26. doi: 10.1053/j.ackd.2012.01.001. Adv Chronic Kidney Dis. 2012. PMID: 22364797 Review.

9

Red blood cell transfusion use in patients with chronic kidney disease.

Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD. Gill KS, et al. Among authors: bradbury bd. Nephrol Dial Transplant. 2013 Jun;28(6):1504-15. doi: 10.1093/ndt/gfs580. Epub 2013 Feb 6. Nephrol Dial Transplant. 2013. PMID: 23389999

10

RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.

Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. Gilbertson DT, et al. Among authors: bradbury bd. Am J Kidney Dis. 2013 Nov;62(5):919-28. doi: 10.1053/j.ajkd.2013.05.004. Epub 2013 Jun 28. Am J Kidney Dis. 2013. PMID: 23815986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page